The Missing Ingredient in Both Medicine and Fiction: A Human-Scale Reason

What if the real problem is not diversity, but sameness of expectation?

Here is a provocative thought: many failures in medicine and storytelling come from the same blind spot. We build systems, models, and plots as if one kind of human being, one kind of reaction, one kind of emotional logic were enough to stand in for everyone. Then we are surprised when the world refuses to cooperate.

In clinical research, that blind spot can be dangerous. A drug may work beautifully for one group and fail, or even harm, another. In fiction, the same blind spot can make a strange story feel hollow, no matter how inventive the surface is. A scene can be absurd, surreal, or wildly original, but if it does not carry an emotional center, the audience feels the emptiness immediately.

The deeper connection between these two domains is not just that both involve human variation. It is that both depend on translation. Biology translates a drug into an outcome. Fiction translates an event into meaning. And in both cases, the translation fails when we assume the same input will produce the same effect in every person.

The world is not one audience and not one body. It is many bodies, many temperaments, many ways of converting input into consequence.

---

The illusion of the universal person

For a long time, medicine often behaved as though the human body were a standardized machine with interchangeable parts. Give the same medication, expect the same result. But reality is messier. Some groups metabolize drugs differently because of genetics, environment, diet, or other factors that medicine has historically undermeasured. A striking example is clopidogrel, a widely used antiplatelet drug. In some populations, including many Pacific Islanders, a large fraction cannot convert it into its active form effectively. The treatment is present, but the benefit never fully arrives.

That is not a minor technicality. It means that what looks like equal treatment can actually be unequal effect. The prescription is the same, yet the lived outcome is different. The system mistakes sameness of procedure for sameness of result.

Fiction has its own version of this mistake. A writer can assemble all the correct ingredients of originality: strange images, eccentric characters, surreal events. But if everything is merely bizarre for its own sake, the story becomes a display case of oddity rather than an experience. The surface may be novel, but the underlying emotional translation is absent. The reader can tell when the work is not moving toward a human truth, only toward novelty.

This is why so much experimental art feels thin after the first surprise. It has difference without consequence. It has motion without feeling. It is the narrative equivalent of prescribing the same drug to everyone and assuming the chemistry will sort itself out.

---

Why variety alone is not enough

It would be easy to say that the answer in both medicine and fiction is simply more diversity. But that is only the beginning. Diversity matters because it reveals hidden variation, yet diversity by itself does not solve the deeper problem. The real challenge is not merely to include different people or different forms. It is to understand the logic of conversion.

In medicine, that means asking: how does this body process this intervention? What conditions change the outcome? Which populations were invisible when the treatment was tested? In storytelling, it means asking: what emotional mechanism makes this weirdness matter? What feeling does this strangeness sharpen, expose, or release?

Without that second question, diversity can become decorative. A clinical trial may recruit a broader sample but still ignore the variables that actually alter response. A story may become more eccentric but still fail to land because the eccentricity is not in service of any emotional design.

The subtle truth is that difference is not the destination. Difference is the diagnostic tool that reveals whether our model is real.

A useful analogy comes from music. Two instruments can play the same note, but the note will not be heard the same way in every hall, by every listener, or in every arrangement. The question is not just whether the note exists. The question is what the system does with it. Clinical research and fiction both require this kind of acoustics, a sensitivity to how context shapes transmission.

---

The emotional point is the active metabolite of a story

One of the most useful ideas hidden in the intersection of these passages is this: emotion is to fiction what the active metabolite is to medicine.

A medication may enter the body in one form, but it only matters if it becomes the form that actually produces the effect. In the same way, a story may begin with absurd events, impossible situations, or comic nonsense, but it only matters if those events convert into felt significance. Without that conversion, the reader experiences texture but not meaning.

This explains why some absurd stories endure while others vanish. The difference is not that one is less strange. It is that one has an emotional consequence. Even if the plot is disorienting, we can feel grief, longing, humiliation, loneliness, or hope organizing the chaos from within. The story becomes more than a sequence of events because it metabolizes into affect.

This also explains why many works that aim for “edginess” feel forgettable. They mistake distortion for depth. They add noise but not emotional chemistry. In medicine, that would be like deploying a drug delivery system that never releases the active compound. The package arrives. The cure does not.

A story without emotional conversion is not surreal, it is inert.

This is a powerful standard for creators. When you introduce a strange image, a bizarre premise, or an experimental structure, ask a hard question: what feeling becomes more accessible because of this form? If you cannot answer, the strangeness may be ornamental rather than necessary.

---

Systems fail when they confuse average with adequate

Both clinical research and literature reveal a deeper cultural habit: we trust averages too much. An average response can conceal devastating disparities. A “successful” drug in a population trial may still fail many individuals. A story praised for originality may still leave readers cold if it does not account for the emotional range of actual humans.

This is the trap of optimization at scale. Systems are built for what is most common, not what is most consequential at the margins. But the margins are often where truth lives. A therapy that does not work for a high proportion of a population is not really universal, no matter how confident the label. A story that only works if the reader shares the author’s private logic is not truly communicative.

This is why both medicine and art need humility. The clinician must accept that the body is not a generic container. The writer must accept that the reader is not a passive recipient. Each person brings a distinct interpretive and biological environment. The same intervention arrives into a different ecology every time.

Think of a recipe that calls for salt. In one kitchen, the result is balanced. In another, the water content, heat, or ingredients shift the entire dish. The recipe has not failed because of one bad cook. It has revealed a hidden dependency. Likewise, when a treatment or story fails in a subgroup, the failure is not noise. It is information about the real structure of the system.

---

Toward human-scale thinking

The deepest lesson connecting these ideas is that human variation is not an exception to the rule, it is the rule itself. Once you accept that, the goal changes. You stop asking how to force one solution onto everyone and start asking how to design for translation across difference.

In medicine, this means moving beyond one size fits all thinking. It means studying how genetics, ancestry, environment, and behavior alter response, then building clinical practice around that variation rather than pretending it is peripheral. In fiction, it means recognizing that aesthetic daring must remain answerable to emotional intelligibility. Weirdness should not abolish feeling. It should intensify it.

This is a surprisingly unifying principle: the best systems do not erase difference. They route through it.

A good physician does not ignore a patient’s uniqueness in order to fit them into the protocol. A good storyteller does not ignore emotional coherence in order to showcase cleverness. Both are trying to create a passage between form and human consequence. The passage may be messy, nonlinear, or surprising, but it must exist.

That is why the most useful innovations often look less like breakthroughs and more like better attunement. They notice what was always there but poorly measured. They accept that the body, like the imagination, is a variable medium. They ask not only “What works?” but “For whom, under what conditions, and at what cost?”

---

Key Takeaways

1. Do not confuse sameness of treatment with sameness of outcome. In medicine, identical prescriptions can produce radically different effects. In creative work, identical structures can produce very different levels of feeling.

2. Ask what translates, not just what exists. A drug must become active in the body. A strange story must become emotionally legible in the reader. Translation is the real test.

3. Use diversity as a diagnostic tool, not a decorative gesture. Variation reveals the hidden assumptions in your model, whether your model is a clinical protocol or a narrative form.

4. Treat emotional coherence as essential, not optional. In fiction, absurdity without feeling is empty. In communication of any kind, novelty without consequence fades fast.

5. Look for the margins, because that is where the system tells the truth. Outliers are not just exceptions. They are often the first clear evidence that the average is misleading.

---

The final test: can your system feel the human being inside the pattern?

The surprising bridge between medicine and fiction is not that both are about people. It is that both must respect the irreducible fact that people are not interchangeable. A drug is not just a drug once it enters a body. A strange story is not just strange once it enters a mind. In both cases, context decides the meaning of the thing.

That is a humbling idea. It tells us that the most elegant system may still fail if it ignores translation, and the most brilliant form may still fail if it ignores feeling. The job is not merely to produce something standardized or something novel. The job is to create something that survives contact with a real human life.

Maybe that is the deepest standard we should apply everywhere, from clinical trials to art: not whether something is clever, universal, or provocative, but whether it can cross the distance between design and lived experience without losing its soul.

Because in the end, the real measure of any intervention, whether a medicine or a story, is simple: does it become active in a human being?